
A NEW CLOCK IS RUNNING FOR MULTIPLE MYELOMA:
CIRCADIAN CLOCK PROTEIN-PERIOD 3 (PER-3)
POLYMORPHISM Serin I.1,*, Pehlivan S.2, Demir I.3, Oyacı Y.2, Pehlivan M.3 *Corresponding Author: Istemi Serin, M.D., University of Health Sciences, Istanbul Training and
Research Hospital, Department of Hematology, Org. Nafiz GURMAN Cad., Fatih, 34098
tel.: +90 532 3172393, e-mail: serinistemi@hotmail.com page: 37
|
REFERENCES
1. Rajkumar SV. Multiple myeloma: 2020 update on
diagnosis, risk-stratification and management [published
correction appears in Am J Hematol. 2020 Nov;
95(11):1444]. Am J Hematol. 2020;95(5):548-567.
doi:10.1002/ajh.25791
2. Siegel RL, Miller KD, Jemal A. Cancer statistics,
2020. CA Cancer J Clin. 2020; 70(1): 7-30.
doi:10.3322/caac.21590
3. Kyle RA, Therneau TM, Rajkumar SV, Larson DR,
Plevak MF, Melton LJ. 3rd. Incidence of multiple
myeloma in Olmsted County, Minnesota: Trend
over 6 decades. Cancer. 2004; 101(11) :2667-2674.
doi:10.1002/cncr.20652
4. Scheiermann C, Gibbs J, Ince L, Loudon A. Clocking
in to immunity. Nat Rev Immunol. 2018; 18(7):
423-437. doi:10.1038/s41577-018-0008-4
5. Labrecque N, Cermakian N. Circadian Clocks in the
Immune System. J Biol Rhythms. 2015; 30(4): 277-
290. doi:10.1177/0748730415577723
6. Guess J, Burch JB, Ogoussan K, Armstead CA, Zhang
H, Wagner S et al. Circadian disruption, Per3, and
human cytokine secretion. Integr Cancer Ther. 2009;
8(4): 329-336. doi:10.1177/1534735409352029
7. Ebisawa T, Uchiyama M, Kajimura N, Mishima K,
Kamei Y, Katoh M et al. Association of structural
polymorphisms in the human period3 gene with delayed
sleep phase syndrome. EMBO Rep. 2001; 2(4):
342-346. doi:10.1093/embo-reports/kve070
8. Helvaci N, Oguz SH, Kabacam S, Karabulut E,
Akbiyik F, Alikasifoglu M et al. Clock gene PERIOD3
polymorphism is associated with susceptibility
to Graves’ disease but not to Hashimoto’s thyroiditis.
Chronobiol Int. 2019; 36(10): 1343-1350. doi:1
0.1080/07420528.2019.1642909
9. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T.
Period3 structural variation: a circadian biomarker associated
with breast cancer in young women. Cancer
Epidemiol Biomarkers Prev. 2005; 14(1): 268-270.
10. Miller SA, Dykes DD, Polesky HF. A simple salting
out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.
doi:10.1093/nar/16.3.1215
11. Nursal A, Cetinay Aydin P, Uysal M, Pehlivan M,
Oyacı Y, Pehlivan S. PER3 VNTR variant and susceptibility
to smoking status/substance use disorder in
a Turkish population. Archives of Clinical Psychiatry
(São Paulo). 47. 10.1590/0101-60830000000235.
12. Dagmura H, Yiğit S, Nursal AF, Duman E, Gumusay
O. Possible Association of PER2/PER3 Variable
Number Tandem Repeat Polymorphism Variants with
Susceptibility and Clinical Characteristics in Pancreatic
Cancer. Genet Test Mol Biomarkers. 2021; 25(2):
124-130. doi:10.1089/gtmb.2020.0179
13. Geng P, Ou J, Li J, Wang N, Xie G, Sa R et al. Genetic
association between PER3 genetic polymorphisms
and cancer susceptibility: a meta-analysis. Medicine
(Baltimore). 2015; 94(13): e568. doi:10.1097/
MD.0000000000000568
14. Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou
A, Karantanou C, Stravopodis DJ et al. Association
of the clock genes polymorphisms with
colorectal cancer susceptibility. J Surg Oncol. 2013
Dec; 108(8): 563-7. doi: 10.1002/jso.23434.
15. Alexander M, Burch JB, Steck SE, Chen CF, Hurley
TG, Cavicchia P et al. Case-control study of the PERIOD3 clock gene length polymorphism and colorectal
adenoma formation. Oncol Rep. 2015; 33(2): 935-
941. doi:10.3892/or.2014.3667
16. Gutiérrez-Monreal MA, Villela L, Baltazar S, Perfecto-
Avalos Y, Cardineau GA, Scott SP. A PER3
polymorphism is associated with better overall survival
in diffuse large B-cell lymphoma in Mexican
population. Cancer Biomark. 2015; 15(5): 699-705.
doi:10.3233/CBM-150511
17. Yang MY, Lin PM, Hsiao HH, Hsu JF, Lin HY, Hsu
CM et al. Up-regulation of PER3 Expression Is Correlated
with Better Clinical Outcome in Acute Leukemia.
Anticancer Res. 2015; 35(12): 6615-6622.
18. Motivala SJ, Levin MJ, Oxman MN, Irwin MR. Impairments
in health functioning and sleep quality in
older adults with a history of depression. J Am Geriatr
Soc. 2006; 54(8): 1184-1191. doi:10.1111/j.1532-
5415.2006.00819.x
19. Vgontzas AN, Chrousos GP. Sleep, the hypothalamicpituitary-
adrenal axis, and cytokines: multiple interactions
and disturbances in sleep disorders. Endocrinol
Metab Clin North Am. 2002; 31(1): 15-36.
doi:10.1016/s0889-8529(01)00005-6
20. Vgontzas AN, Zoumakis M, Bixler EO, Lin HM,
Prolo P, Vela-Bueno A et al. Impaired nighttime
sleep in healthy old versus young adults is associated
with elevated plasma interleukin-6 and cortisol
levels: physiologic and therapeutic implications. J
Clin Endocrinol Metab. 2003; 88(5): 2087-2095.
doi:10.1210/jc.2002-021176
21. Ria R, Melaccio A, Racanelli V, Vacca A. Anti-VEGF
Drugs in the Treatment of Multiple Myeloma Patients.
J Clin Med. 2020; 9(6): 1765. Published 2020
Jun 6. doi:10.3390/jcm9061765
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|